Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8 T cells [dataset 1]
Single-cell RNA-seq · human · 360 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart. Read from the summary: GEO's own type field only says 'expression profiling by sequencing', so confirm it in the paper.
- Organism
- Homo sapiens (human)
- Topic
- MelanomaThis series is part of our curated briefing on it.
- Samples
- 360 samples: 60 conditions, mostly with about 8 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8(+) T cellsCancer cell · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE272993_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1138883 and SRA study SRP521777. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 355 samples.
How we read this: 60 replicated groups read from 360 sample titles; they account for 355 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8416211 Feature-2020-07-10-1-2 Feature-2020-07-10-1
- GSM8416212 GEX-2020-07-10-1-2 GEX-2020-07-10-1
- GSM8416213 TCR-2020-07-10-1-2 TCR-2020-07-10-1
- GSM8416214 Feature-2020-07-10-1-3 Feature-2020-07-10-1
- GSM8416215 GEX-2020-07-10-1-3 GEX-2020-07-10-1
- GSM8416216 TCR-2020-07-10-1-3 TCR-2020-07-10-1
- GSM8416217 Feature-2020-07-10-1-4 Feature-2020-07-10-1
- GSM8416218 GEX-2020-07-10-1-4 GEX-2020-07-10-1
- GSM8416219 TCR-2020-07-10-1-4 TCR-2020-07-10-1
- GSM8416220 Feature-2020-07-10-1-5 Feature-2020-07-10-1
- GSM8416221 GEX-2020-07-10-1-5 GEX-2020-07-10-1
- GSM8416222 TCR-2020-07-10-1-5 TCR-2020-07-10-1
- GSM8416223 Feature-2020-07-10-1-6 Feature-2020-07-10-1
- GSM8416224 GEX-2020-07-10-1-6 GEX-2020-07-10-1
- GSM8416225 TCR-2020-07-10-1-6 TCR-2020-07-10-1
- GSM8416226 Feature-2020-08-17-1-1 Feature-2020-08-17-1
- GSM8416227 TCR-2020-08-17-1-1 TCR-2020-08-17-1
- GSM8416228 Feature-2020-08-17-1-2 Feature-2020-08-17-1
- GSM8416229 TCR-2020-08-17-1-2 TCR-2020-08-17-1
- GSM8416230 Feature-2020-08-17-1-3 Feature-2020-08-17-1
- GSM8416231 GEX-2020-08-17-1-3 GEX-2020-08-17-1
- GSM8416232 TCR-2020-08-17-1-3 TCR-2020-08-17-1
- GSM8416233 Feature-2020-08-17-1-4 Feature-2020-08-17-1
- GSM8416234 GEX-2020-08-17-1-4 GEX-2020-08-17-1
- GSM8416235 TCR-2020-08-17-1-4 TCR-2020-08-17-1
- GSM8416236 Feature-2020-08-17-1-5 Feature-2020-08-17-1
- GSM8416237 GEX-2020-08-17-1-5 GEX-2020-08-17-1
- GSM8416238 TCR-2020-08-17-1-5 TCR-2020-08-17-1
- GSM8416239 Feature-2020-08-17-1-6 Feature-2020-08-17-1
- GSM8416240 GEX-2020-08-17-1-6 GEX-2020-08-17-1
- GSM8416241 TCR-2020-08-17-1-6 TCR-2020-08-17-1
- GSM8416242 Feature-2020-08-19-1-1 Feature-2020-08-19-1
- GSM8416243 GEX-2020-08-19-1-1 GEX-2020-08-19-1
- GSM8416244 TCR-2020-08-19-1-1 TCR-2020-08-19-1
- GSM8416245 Feature-2020-08-19-1-2 Feature-2020-08-19-1
- GSM8416246 GEX-2020-08-19-1-2 GEX-2020-08-19-1
- GSM8416247 TCR-2020-08-19-1-2 TCR-2020-08-19-1
- GSM8416248 Feature-2020-08-19-1-3 Feature-2020-08-19-1
- GSM8416249 GEX-2020-08-19-1-3 GEX-2020-08-19-1
- GSM8416250 TCR-2020-08-19-1-3 TCR-2020-08-19-1
+ 320 more — browse all 360 samples with per-sample file links →
- GSE91061 Molecular portraits of tumor mutational and micro-environmental sculpting by immune checkpoint blockade therapy 109 samples same disease briefing · shares therapy
- GSE100797 Mutational and neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma 25 samples same disease briefing · shares therapy
- GSE317605 A Phase II Trial of Pembrolizumab plus Granulocyte Macrophage Colony Stimulating Factor in Advanced Biliary Cancer [CITE-Seq] 168 samples same disease briefing
- GSE142751 Genome-wide maps of chromatin state in 142 cancer cell lines [cell line] 855 samples same disease briefing
- GSE12391 Melanoma: comparison between common nevi, radial/vertical growth phase melanoma, metastases and dysplastic nevi 114 samples same disease briefing
- GSE134459 Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 73 samples same disease briefing
- GSE230489 RNA-sequencing of cutaneous melanoma and non-small cell lung cancer biopsies 38 samples same disease briefing
- GSE123728 Clinical and Immunologic Activity of a Single Dose of Neoadjuvant PD-1 Blockade and Predictors of Clinical Outcomes in Resectable Melanoma 24 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.